DSIP (delta sleep-inducing peptide) was first isolated from rabbit cerebral venous blood in 1974 and has accumulated a small but published clinical-trial base most notably a 1992 Schneider-Helmert study showing improved sleep with DSIP infusion in chronic insomniacs over 7 successive nights and earlier studies showing improved sleep duration in middle-aged chronic insomniacs
Studies have shown that Epithalon treatment can increase telomerase activity measured by the TRAP assay in cultured human cells, correlating with measurable telomere elongation
How Women Are Using BPC-157 for Wellness and Recovery Whether youre healing from a recent injury or looking for a gentle nudge toward better energy and digestion, women are turning to BPC-157 for: Injury and surgery recovery : Speeds healing for soft tissue, joints, and tendons
The review identifies advantages such as high specificity and potency, alongside challenges including stability concerns and delivery limitations
Anti-inflammatory Effects: The peptide appears to reduce inflammation by modulating cytokines and other mediators, helping decrease swelling and pain associated with injuries
Health authorities discourage its use due to insufficient human safety data, and some jurisdictions have restricted it as a prescription-only medicine despite it not being available through legitimate prescriptions